Skip to main content
OpenTrials
Completed

NCT Number: NCT01155687

Psychosocial Counseling in Afghanistan

The assessment intends to investigate the efficacy of psychosocial counseling for the treatment of help seeking individuals with psychosocial problems in Mazar-e-Sharif, Afghanistan. Treatment was administered by local counselors who had received specific education and training

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mental Health Anxiety Disorders Behavior Behavioral Symptoms Depression Mental Disorders Personal Satisfaction Psychological Well-Being Stress

Age range

14 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Counseling Center Mazar-e-Sharif

Mazari Sharif, Balkh, Afghanistan

About this study

Psychosocial stress due to conflict and war causes major mental health problems in many resource-poor countries, especially those coping with ongoing war-like conditions. There is a lack of intervention research in these population. The purpose of this assessment was to examine whether the type of psychosocial counseling developed by our group is effective in reducing symptoms of depression and anxiety and significantly increasing the quality of life of help-seeking Afghans.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of mental health problems by a local medical doctor

Exclusion criteria

  • Schizophrenia
  • Mental retardation

Treatment and study plan

Primary outcomes

  1. HSCL 25

    Time frame: Symptoms were assessed at baseline

    Symptoms of Depression and Anxiety measured with the HSCL 25

  2. HSCL 25

    Time frame: 3-month follow-up

    Symptoms of Depression and Anxiety measured with the HSCL 25

  3. HSCL 25

    Time frame: Assessment at 12-month-follow-up

    Symptoms of Depression and Anxiety measured with the HSCL 25

Secondary outcomes

  1. M.I.N.I. (Mini-International Neuropsychiatric Interview)

    Time frame: Symptoms were assessed at baseline

    To assess, if the patients have a current Major Depression, the depression section from the "Mini-International Neuropsychiatric Interview" (Sheehan, & Janavs, 1998) was included

  2. Psychosocial stressors and coping mechanism

    Time frame: Symptoms were assessed at baseline

    Psychosocial stressors and coping mechanism of the participants were investigated in expert interviews

  3. Screening for Depression

    Time frame: Symptoms were assessed at baseline

    A culturally grounded assessment measure developed in close collaboration with a team of Afghan experts explored current depressive symptoms

  4. M.I.N.I. (Mini-International Neuropsychiatric Interview)

    Time frame: Assessment at 3-month-follow-up

    To assess, if the patients have a current Major Depression, the depression section from the "Mini-International Neuropsychiatric Interview" (Sheehan, & Janavs, 1998) was included

  5. M.I.N.I (Mini-International Neuropsychiatric Interview)

    Time frame: Assessment at 12-month-follow-up

    To assess, if the patients have a current Major Depression, the depression section from the "Mini-International Neuropsychiatric Interview" (Sheehan, & Janavs, 1998) was included

  6. Psychosocial stressors and coping mechanism

    Time frame: Assessment at 3-month-follow-up

    Psychosocial stressors and coping mechanism of the participants were investigated in expert interviews

  7. Psychosocial stressors and coping mechanism

    Time frame: Assessment at 12-month-follow-up

    Psychosocial stressors and coping mechanism of the participants were investigated in expert interviews

  8. Screening for Depression

    Time frame: Assessment at 3-month-follow-up

    A culturally grounded assessment measure developed in close collaboration with a team of Afghan experts explored current depressive symptoms

  9. Screening for Depression

    Time frame: Assessment at 12-month-follow-up

    A culturally grounded assessment measure developed in close collaboration with a team of Afghan experts explored current depressive symptoms

Sponsors and collaborators

Lead sponsor

University of Konstanz

Other

Collaborators

  • European Union

Registry information

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Jul 2, 2010
Registry last updated
Aug 9, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.